Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2026, 35(3):138-145

Infective endocarditis - The 16-year experience of one centre

Peter Snopek1, 2, Jozef Hasilla1, 2, Jakub Benko1, 3
1 Kardiologická klinika FN Nitra
2 Fakulta sociálnych vied a zdravotníctva, Univerzita Konštatína Filozofa, Nitra
3 I. interná klinika, Univerzitná nemocnica Martin, Slovenská republika

Background: Infective endocarditis (IE) is a serious disease, the incidence and mortality of which remain high despite advances in medicine. We decided to investigate its etiology, echocardiographic findings, comorbidities, complications, and their impact on mortality in a group of patients hospitalized for infective endocarditis (IE) at the Cardiology Department of the University Hospital Nitra from 1. 1. 2008 to 31. 12. 2023.

Methodology: Retrospective analysis of patients hospitalized for IE at the Cardiology Department of the University Hospital Nitra from January 1, 2008, to December 31, 2023.

Results: During the 16-year follow-up, 170 patients (118 men and 52 women) were hospitalized for IE. Patients aged 46-65 years were the largest group (62 patients). The most common comorbidity was arterial hypertension (52%), and the most common initial symptom was fever (63%). IE of the mitral and aortic valves prevailed (153 patients); the mitral valve was most frequently affected (65 patients), and staphylococci were most frequently responsible for IE (48 patients). 33 patients (19.4%) underwent cardiac surgery. Hospital mortality was 10.6%, 30-day 15.3% and annual 24.1%. Multivariate Cox regression-analysis confirmed heart failure (HF) as the strongest independent statistically significant predictor of patient death regardless of whether it was in-hospital, monthly, annual, or 16-year mortality. Diabetes mellitus (DM), age, and embolic complications had a similar negative impact on survival, but multivariate regression did not confirm their statistical significance, regardless of whether mortality was in-hospital, monthly, annual, or 16-year.

Conclusion: Middle-aged men with left-sided valve disease were hospitalized more frequently for IE. The most common causative agent was staphylococci; in-hospital mortality was slightly lower than reported in the literature (13-26% in developed countries). We identified SZ as the strongest statistically significant predictor of death.

Keywords: infective endocarditis; etiological agent; complications; cardiac surgery; mortality

Published: August 1, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Snopek P, Hasilla J, Benko J. Infective endocarditis - The 16-year experience of one centre. Cardiology Letters. 2026;35(3):138-145.
Download citation

References

  1. Hubers SA, DeSimone DC, Gersh BJ, Anavekar NS. Infective Endocarditis: A Contemporary Review. Mayo Clin Proc. 2020;95:982-997.
  2. Miao H, Zhang Y, Zhang Y, Zhang J. Update on the epidemiology, diagnosis, and management of infective endocarditis: A review. Trends Cardiovasc Med. 2024;34:499-506.
  3. Delgado V, Ajmone Marsan N, de Waha S, Bonaros N, Brida M, Burri H, et al. ESC Scientific Document Group. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J. 2023;44:3948-4042.
  4. Li M, Kim JB, Sastry BKS, Chen M, et al. Infective endocarditis. Lancet. 2024;40:377-392.
  5. Rajani R, Klein JL. Infective endocarditis: A contemporary update. Clin Med (Lond). 2020;20:31-35.
  6. Mills MT, Al-Mohammad A, Warriner DR. Changes and advances in the field of infective endocarditis. Br J Hosp Med (Lond). 2022;83:1-11.
  7. Burban A, Słupik D, Reda A, Szczerba E, Grabowski M, Kołodzińska A. Novel Diagnostic Methods for Infective Endocarditis. Int J Mol 2024;25:1245.
  8. Chirillo F. New approach to managing infective endocarditis. Trends Cardiovasc Med. 2021;31:277-286.
  9. Khan MZ. Racial and Gender Trends in Infective Endocarditis Related Deaths in United States (2004-2017). Am J Cardiol. 2020;129:25-126.
  10. Sanaiha Y, Lyons R, Benharash P. Infective endocarditis in intravenous drug users. Trends Cardiovasc Med. 2020;30:491-497.
  11. Pereira SC, Abrantes AL, António PS, Morais P, Sousa C, David C. Infective endocarditis risk in patients with bicuspid aortic valve: Systematic review and meta-analysis. Int J Cardiol Heart Vasc. 2023;47:101249.
  12. Cuervo G, Quintana E, Regueiro A, Perissinotti A, Vidal B, Miro JM. The Clinical Challenge of Prosthetic Valve Endocarditis: JACC Focus Seminar 3/4. J Am Coll Cardiol. 2024;83:1418-1430.
  13. Tzoumas A, Sagris M, Xenos D, Ntoumaziou A, Kyriakoulis I, Kakargias F, et al. Epidemiological Profile and Mortality of Infective Endocarditis Over the Past Decade: A Systematic Review and Meta-Analysis of 133 Studies. Am J Cardiol. 2025;244:67-88.
  14. Safia O, Asma J, Hana H, Sarra J, Aymen Z, Mouna J, et al. Endocardite infectieuse: facteurs prédictifs de mortalité intrahospitalière [Infective endocarditis: In-hospital mortality predictive factors]. Ann Cardiol Angeiol (Paris). 2024;73:101740.
  15. Mistiaen WP. What are the main predictors of in-hospital mortality in patients with infective endocarditis: a review. Scand Cardiovasc J. 2018;52:58-68.
  16. Jensen AD, Østergaard L, Graversen PL, Hadji-Turdeghal K, Petersen JK, Rossing P, et al. Infective endocarditis and relationship with diabetes mellitus - Patient characteristics, microbial etiology and mortality. Infection. 2025;53:2757-2767.
  17. Bohbot Y, Habib G, Laroche C, Stöhr E, Chirouze C, HernandezMeneses M, et al. EORP EURO-ENDO Registry Investigators Group. Characteristics, management, and outcomes of patients with left-sided infective endocarditis complicated by heart failure: a substudy of the ESC-EORP EURO-ENDO (European infective endocarditis) registry. Eur J Heart Fail. 2022;24:253-1265.
  18. Lovelock T, Zhu MZL, Saran A, Vasudevan T. Embolic phenomena to the limbs are an independent predictor of in-hospital mortality from infective endocarditis. ANZ J Surg. 2022;92:2312-2317.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.